Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 616 AL 630

Potential Vitamin B6 Depletion During Carbidopa/Levodopa Therapy in Parkinson's Disease: A Scoping Review of Direct Evidence

Sielaff P, Lis M, Pawłasek J, Koch RR, Sucharski M, Michałowicz B, Cierpiał P, Puziuk M, Mikołajczak P, Staranowicz A, Dziurzyńska M, Dziurzyński P, Kiełbasiewicz M, Piwar H.

Cureus. 2026 Aug 7;18(8):e114123. doi: 10.7759/cureus.114123. eCollection 2026 Aug.

The neutrophil-to-lymphocyte ratio in Parkinson's disease: a systematic review and meta-analysis of its association with differential diagnosis, severity, and prognosis

Cabanillas-Lazo M, Montes-Baldarrago A, Uriol-Alvino S, Baltazar-Ñahui H, Pereda-Leon NB, Jimenez-Alvarez H, Mayta-Tovalino F.

Clin Park Relat Disord. 2026 Aug 15;15:100494. doi: 10.1016/j.prdoa.2026.100494. eCollection 2026.

Japanese translation of lindop parkinson's disease mobility assessment (LPA): validity and reliability study

Taniguchi S, Marumoto K, Narita M, Kawami Y, Kozuki T, Matsuda T, Miura K, Ge L, Okada Y, Ikenaka K.

Neurol Sci. 2026 Sep 8;47(10):765. doi: 10.1007/s10072-026-09370-0.

The Role of Probiotics in Parkinson's Disease - Current Evidence and Future Perspectives

Dadak Yıldırım E, Yıldırım İG.

J Diet Suppl. 2026 Sep 8:1-20. doi: 10.1080/19390211.2026.2729425. Online ahead of print.

Clinical applications of invasive spinal cord stimulation in neurological disorders: a narrative review

He M, Tan Y, He Z, Yu S, Zhang C, Deng Y.

Front Neurol. 2026 Aug 26;17:1872091. doi: 10.3389/fneur.2026.1872091. eCollection 2026.

Interaction between N6-methyladenosine (m(6)A) modification and toxicant-related neurodegeneration: From neural development to pathophysiology

She Z, Huang P, Luo S, Zhang L, Peng H, Tang Y, Chen Y, Luo J, Duan W, Liu L, Liu L.

Genes Dis. 2025 Dec 17;13(5):101984. doi: 10.1016/j.gendis.2025.101984. eCollection 2026 Sep.

Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies

Stephenson D, Concha-Marambio L, Lanz T, Merchant K, Brockmann K, King N, Carrillo L, Pedata A, Kocherla H, Hutten SJ; Critical Path for Parkinson's Consortium.

J Parkinsons Dis. 2026 Sep;16(6):1296-1312. doi: 10.1177/1877718X261463936. Epub 2026 Jul 24.

Validating wearable sensors as an assessment tool for Parkinson's disease

Silis K, Kieran NW, Shawki N, Madarshahian S, Liang TW, Serruya M.

Disabil Rehabil. 2026 Sep;48(19):6361-6371. doi: 10.1080/09638288.2026.2629784. Epub 2026 Mar 4.

Treatment of Parkinson's Disease-Related Psychosis

Rocha NP, Moreira Sassi KL, Furr Stimming E, Teixeira AL.

Clin Pharmacol. 2026 Sep 5;18:575991. doi: 10.2147/CPAA.S575991. eCollection 2026.

Midbrain organoids as next-generation models for Parkinson's disease: From pathogenesis to therapeutic discovery

Jiang DY, Yao SY, Du MQ, Lin LX, Kang XH, Peng Y.

Exp Neurol. 2026 Sep 11;407:116022. doi: 10.1016/j.expneurol.2026.116022. Online ahead of print.

Fatigue and fatigability in Parkinson's disease: a neurophysiological perspective

Pauletti C, Zampogna A, Patera M, Falletti M, Fattapposta F, Suppa A.

Clin Neurophysiol. 2026 Sep 9;192:2112402. doi: 10.1016/j.clinph.2026.2112402. Online ahead of print.

Preface to the Special Issue: "Microbiota and Gut-Brain Axis"

Clarke G.

J Neurochem. 2026 Sep;170(9):e70555. doi: 10.1111/jnc.70555.

A systematic review of Mendelian randomization evidence on alcohol-related phenotypes and multiple human diseases

Kassaw NA, Stacey D, Mulugeta A, Zhou A, Lee SH, Hyppӧnen E.

Drug Alcohol Depend. 2026 Aug 26;288:113330. doi: 10.1016/j.drugalcdep.2026.113330. Online ahead of print.

Clinical utility of DaTscan in clinically uncertain parkinsonian syndromes: a systematic review and meta‑analysis

Rissardo JP, Patino J, Caprara ALF, McGarry A.

J Clin Neurosci. 2026 Sep 17;154:112305. doi: 10.1016/j.jocn.2026.112305. Online ahead of print.

Early clinical experience with IPX203 in Parkinson's disease with motor fluctuations

Isaacson S, Jost WH, Isaacson J.

J Neural Transm (Vienna). 2026 Sep 22. doi: 10.1007/s00702-026-03299-6. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias